These are the stocks posting the largest moves before the bell.Market Insiderread more
The presidential campaign is "going to be very tough," the former chief White House strategist.Politicsread more
Huawei launched a new 5G flagship smartphone lineup Thursday without pre-installed Google-licensed apps as the Chinese tech giant faces fallout from a U.S. blacklist earlier...Technologyread more
Warren Buffet and Jamie Dimon penned an attack on quarterly guidance and the short-term shareholder mindset last year, and support has followed from the Business Roundtable....Evolveread more
Here are the biggest calls on Wall Street on ThursdayInvestingread more
Steve Bannon also says China's attempts to forge a two-tier deal to end the yearlong trade war with the U.S. is "wishful thinking."Politicsread more
Aug 20 (Reuters) - Elanco Animal Health Inc said on Tuesday it would buy Bayer AG's animal health unit in a cash and stock deal valued at $7.6 billion, a move that would create the second largest animal health business and expand Elanco's reach in the pet e-commerce space.
The animal health market has seen Pfizer Inc and Eli Lilly and Co, successfully floating their veterinary medicine units on the stock market as independent entities. The deal is expected to be closed by mid-2020, Elanco said. (Reporting by Aakash Jagadeesh Babu and Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur)